| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
269,190,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile AbCellera is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies to address pandemics and common diseases. Co.'s full-stack, artificial intelligence-, or AI, powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. Rather than advancing its own clinical pipeline of drug candidates, Co. forges partnerships with drug developers of all sizes, from pharmaceutical to small biotechnology companies. In a collaboration with Eli Lilly and Company, Co. has applied its technology stack to co-develop LY-CoV555, a potential antibody therapy to treat and prevent COVID-19.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
267,500 |
881,235 |
| Total Buy Value |
$0 |
$0 |
$1,613,453 |
$7,031,815 |
| Total People Bought |
0 |
0 |
5 |
5 |
| Total Buy Transactions |
0 |
0 |
7 |
13 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lecault Veronique |
Chief Operating Officer |
• • – |
2021-06-09 |
4 |
S |
$25.50 |
$25,500,000 |
I/I |
(1,000,000) |
273,630 |
|
- |
|
| Hansen Carl L. G. |
Chief Executive Officer |
• • • |
2021-06-09 |
4 |
S |
$24.03 |
$144,770,323 |
I/I |
(6,000,000) |
233,500 |
|
- |
|
| Thermopylae Holdings Ltd. |
10% Owner |
– – • |
2021-06-09 |
4 |
S |
$24.03 |
$134,530,033 |
D/D |
(5,598,420) |
55,604,330 |
|
- |
|
| Stimart Tryn |
Chief Legal Officer |
• – – |
2021-06-09 |
4 |
S |
$25.50 |
$25,500,000 |
D/D |
(1,000,000) |
250 |
|
- |
|
| Booth Andrew |
Chief Financial Officer |
• – – |
2021-06-09 |
4 |
S |
$25.50 |
$30,600,000 |
D/D |
(1,200,000) |
0 |
|
- |
|
| Booth Andrew |
Chief Financial Officer |
• – – |
2021-06-07 |
4 |
OE |
$0.19 |
$306,000 |
D/D |
1,200,000 |
1,200,000 |
|
- |
|
| Stimart Tryn |
Chief Legal Officer |
• – – |
2021-06-07 |
4 |
OE |
$0.32 |
$815,000 |
D/D |
1,000,000 |
1,000,250 |
|
- |
|
| Falconer Ester |
Chief Technology Officer |
• – – |
2021-03-19 |
4 |
OE |
$0.03 |
$34,300 |
D/D |
1,000,000 |
1,000,000 |
|
- |
|
| Znm Capital Management, Llc |
10% Owner |
– – • |
2020-12-15 |
4 |
A |
$0.00 |
$0 |
I/I |
29,105,761 |
29,105,761 |
|
- |
|
| Lecault Veronique |
Chief Operating Officer |
• • – |
2020-12-15 |
4 |
B |
$20.00 |
$340,000 |
I/I |
17,000 |
61,580 |
2.66 |
- |
|
| Lecault Veronique |
Chief Operating Officer |
• • – |
2020-12-15 |
4 |
B |
$20.00 |
$120,000 |
D/D |
6,000 |
1,006,000 |
2.81 |
- |
|
| Thiel Peter |
Director |
– • – |
2020-12-15 |
4 |
A |
$0.00 |
$0 |
I/I |
10,468,907 |
24,660 |
|
- |
|
| Thiel Peter |
Director |
– • – |
2020-12-15 |
4 |
B |
$20.00 |
$60,000,000 |
I/I |
3,000,000 |
10,179,880 |
2.1 |
- |
|
| Hayden Michael R |
Director |
– • – |
2020-12-15 |
4 |
B |
$20.00 |
$1,473,300 |
I/I |
73,665 |
118,245 |
2.1 |
- |
|
| Hayden Michael R |
Director |
– • – |
2020-12-15 |
4 |
A |
$0.00 |
$0 |
I/I |
117,647 |
1,103,397 |
|
- |
|
| Hamer John |
Director |
– • • |
2020-12-15 |
4 |
A |
$0.00 |
$0 |
I/I |
29,105,761 |
29,105,761 |
|
- |
|
| Stimart Tryn |
Chief Legal Officer |
• – – |
2020-12-15 |
4 |
B |
$20.00 |
$5,000 |
I/I |
250 |
250 |
1.99 |
- |
|
| Stimart Tryn |
Chief Legal Officer |
• – – |
2020-12-15 |
4 |
B |
$20.00 |
$5,000 |
D/D |
250 |
250 |
2.74 |
- |
|
| Montalbano John S. |
Director |
– • – |
2020-12-15 |
4 |
B |
$20.00 |
$100,000 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
| Montalbano John S. |
Director |
– • – |
2020-12-15 |
4 |
B |
$20.00 |
$400,000 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| Thermopylae Holdings Ltd. |
10% Owner |
– – • |
2020-12-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
61,202,750 |
|
- |
|
| Hayden Michael R |
Director |
– • – |
2020-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,030,330 |
|
- |
|
| Hansen Carl L. G. |
Chief Executive OfficerOfficer |
• • • |
2020-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
61,827,830 |
|
- |
|
| Lecault Veronique |
Chief Operating OfficerOfficer |
• • – |
2020-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,473,218 |
|
- |
|
| Thiel Peter |
Director |
– • – |
2020-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
891,520 |
|
- |
|
77 Records found
|
|
Page 3 of 4 |
|
|
